Persistent Asset Partners »

Entera Bio shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Entera Bio (ENTX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Entera Bio

Tip: Access up to 7 years of quarterly data

All positions including Entera Bio held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entera Bio by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.5k 5.9k 1.11

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Entera Bio

Knoll Capital Management
Marshall Wace
Parkman Healthcare Partners
Citadel Advisors
Seven Fleet Capital Management
Northern Trust
Renaissance Technologies
Susquehanna International
Schonfeld Strategic Advisors
Signature Estate and Investment Advisors
HighTower Advisors
Jane Street
Geode Capital Management
Superstring Capital Management
Hrt Financial

View all funds holding Entera Bio